Skip to main content
Zhong Ji Longevity Science Group Limited logo

Zhong Ji Longevity Science Group Limited — Investor Relations & Filings

Ticker · 767 HKEX Financial and insurance activities
Filings indexed 18 across all filing types
Latest filing 2026-02-10 Board/Management Inform…
Country HK Hong Kong
Listing HKEX 767

About Zhong Ji Longevity Science Group Limited

http://www.irasia.com/listco/hk/zhongji…

Zhong Ji Longevity Science Group Limited is an investment holding company operating in two primary business segments: longevity science and financial services. The longevity science division focuses on biotech research and development, utilizing cell technology and supplements for human health improvement. This includes operating an international clinical cell bank for immune and stem cells, which meets global standards such as FDA, AABB, and cGMP. Additionally, this segment provides diagnostic consultation, medical testing, and healthcare product distribution. The financial services segment involves money lending, provision of credits, financing, and investment consulting services, primarily conducted in Hong Kong and Mainland China.

Recent filings

Filing Released Lang Actions
APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND MEMBER OF THE BOARD COMMITTEES; AND COMPLIANCE WITH RULE 3.10(2) AND 3.21 OF THE LISTING RULES
Board/Management Information Classification · 1% confidence The document is an official announcement from Zhong Ji Longevity Science Group Limited regarding the appointment of a new independent non-executive director (Ms. Tam Mei Chu) and the resulting compliance with Hong Kong Stock Exchange Listing Rules 3.10(2) and 3.21. This content falls squarely under the category of board and management changes.
2026-02-10 English
FURTHER DELAY IN DESPATCH OF CIRCULAR MAJOR AND CONNECTED TRANSACTION IN RELATION TO ACQUISITION OF 25% ISSUED SHARE CAPITAL OF ASIAN INTEGRATED CELL LABORATORY LIMITED INVOLVING ISSUE OF CONVERTIBLE
Regulatory Filings Classification · 1% confidence The document is a short announcement (under 5,000 characters) from Zhong Ji Longevity Science Group Limited regarding a delay in the dispatch of a circular related to a major and connected transaction (acquisition). It does not contain the full circular or the transaction details themselves, but rather serves as a formal notification of a timeline change. Under the 'Menu vs Meal' rule, this is a regulatory announcement regarding the status of a report/circular, fitting the definition of a Regulatory Filing (RNS) as it pertains to corporate disclosure requirements.
2026-02-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026
Share Issue/Capital Change Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' filed with the Hong Kong Stock Exchange. This is a standard regulatory filing required by the HKEX Listing Rules to report movements in securities, share capital, and treasury shares on a monthly basis. It does not fit into specific categories like 'Earnings Release' or 'Annual Report', and it is a recurring regulatory disclosure rather than a one-off announcement, making 'RNS' (Regulatory Filings) the most appropriate classification.
2026-02-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.